Curio to Participate in Upcoming HPIR Roundtable
The HPIR Roundtable enables “match-making” between innovative companies and regional health plans to accelerate the refinement and adoption of transformative healthcare solutions.
PRINCETON, Nov. 28- Curio Digital Therapeutics, Inc. (Curio), the creator of MamaLift, announced today that it was selected by EHIR to participate in the Fall 2022 Health Plan Innovation Roundtable (HPIR) Academy. HPIR’s mission is to drive impact through the adoption of transformative healthcare solutions.
By leveraging the HPIR model, HPIR’s member plans can streamline innovation efforts and one-off vendor requests into a sustainable and proactive process. HPIR identifies and prioritizes emerging solutions that meet the strategic priorities of its health plan members and provides a forum through which health plans can “match” with innovative companies for due diligence, exploration, and pilot implementation. Health plans can share learnings from their implementations and differentiate their value propositions in local markets. HPIR includes 22 regional health plans, representing over 30 million lives.
By participating in the HPIR Academy, Curio will have the opportunity to showcase their suite of products, including MamaLift, MamaLift Plus, and their new risk identification and stratification tool.
“We’re honored to be selected for the Fall 2022 HPIR Academy and look forward to collaborating with innovative thinkers and leaders in the population health space. EHIR is building a truly remarkable community, and we are delighted to have the opportunity to be a part of it,” said Shailja Dixit, MD, MPH, CEO of Curio.
Of approximately 20 nominations, Curio was selected as one of 10 teams to join the Academy Class of Fall 2022.
About Curio Digital Therapeutics, Inc.
Curio Digital Therapeutics, Inc. is a pioneer in developing digital therapeutics solutions and interventions across the behavioral health continuum for women throughout the cycle of life. Curio aims to create a world where every woman can access a behavioral health solution at her fingertips. Curio is reshaping maternal mental health care by leveraging proprietary algorithms, clinically validated screening tools, and personalized digital behavioral interventions to facilitate timely identification and care. For more information, visit Curio at https://www.curiodigitaltx.com/.
Curio Digital Therapeutics Media Contact
Erin Russell,
Senior Vice President of Product Development and Marketing